Other diagnostic tools and biomarkers showing promising results for early stage cancer detection, such as the GALAD (gender, age, L-AFP3, AFP, and des-carboxyprothrombin) risk score, have potential for significant impact through improving surveillance sensitivity [39]. Here, AFP is linked to cancer.